AR008252A1 - Granulado para la preparacion de composiciones farmaccuticas de rrpida desintegracinn y rrpida disolucinn y composiciones farmaccuticas que lo contienen - Google Patents

Granulado para la preparacion de composiciones farmaccuticas de rrpida desintegracinn y rrpida disolucinn y composiciones farmaccuticas que lo contienen

Info

Publication number
AR008252A1
AR008252A1 ARP970102930A ARP970102930A AR008252A1 AR 008252 A1 AR008252 A1 AR 008252A1 AR P970102930 A ARP970102930 A AR P970102930A AR P970102930 A ARP970102930 A AR P970102930A AR 008252 A1 AR008252 A1 AR 008252A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
quick
granulate
preparation
disintegration
Prior art date
Application number
ARP970102930A
Other languages
English (en)
Original Assignee
Astellas Pharma Europ B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8224133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR008252(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astellas Pharma Europ B V filed Critical Astellas Pharma Europ B V
Publication of AR008252A1 publication Critical patent/AR008252A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
ARP970102930A 1996-07-03 1997-07-01 Granulado para la preparacion de composiciones farmaccuticas de rrpida desintegracinn y rrpida disolucinn y composiciones farmaccuticas que lo contienen AR008252A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201829 1996-07-03
US08/770,421 US5837292A (en) 1996-07-03 1996-12-20 Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Publications (1)

Publication Number Publication Date
AR008252A1 true AR008252A1 (es) 1999-12-29

Family

ID=8224133

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102930A AR008252A1 (es) 1996-07-03 1997-07-01 Granulado para la preparacion de composiciones farmaccuticas de rrpida desintegracinn y rrpida disolucinn y composiciones farmaccuticas que lo contienen

Country Status (36)

Country Link
US (1) US5837292A (es)
EP (1) EP0910344B1 (es)
JP (1) JP4159607B2 (es)
CN (1) CN1131025C (es)
AR (1) AR008252A1 (es)
AT (1) ATE237314T1 (es)
AU (1) AU731276B2 (es)
BG (1) BG64114B1 (es)
BR (1) BR9710181B1 (es)
CA (1) CA2258841C (es)
CO (1) CO4890859A1 (es)
CZ (1) CZ295893B6 (es)
DE (1) DE69720995T2 (es)
DK (1) DK0910344T3 (es)
EA (1) EA001537B1 (es)
EG (1) EG23814A (es)
ES (1) ES2197351T3 (es)
HK (1) HK1021511A1 (es)
HU (1) HU225115B1 (es)
ID (1) ID17128A (es)
IL (1) IL127364A (es)
JO (1) JO1969B1 (es)
MY (1) MY116124A (es)
NO (1) NO320767B1 (es)
NZ (1) NZ333247A (es)
PE (1) PE89798A1 (es)
PL (1) PL188235B1 (es)
PT (1) PT910344E (es)
SI (1) SI0910344T1 (es)
SK (1) SK284175B6 (es)
TN (1) TNSN97114A1 (es)
TR (1) TR199802762T2 (es)
TW (1) TW473392B (es)
UA (1) UA61917C2 (es)
WO (1) WO1998001114A1 (es)
ZA (1) ZA975848B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129932A (en) * 1997-09-05 2000-10-10 Merck & Co., Inc. Compositions for inhibiting platelet aggregation
DE19820801A1 (de) * 1998-05-09 1999-11-25 Gruenenthal Gmbh Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
BR9910481A (pt) * 1998-06-11 2001-01-09 Upjohn Co Composição farmacêutica para comprimido de liberação não-contìnua
IT1305308B1 (it) * 1999-03-26 2001-05-04 Biosint S P A Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione
AU4441899A (en) * 1999-05-14 2000-12-05 Eli Lilly And Company Process for preparing pharmaceutical bulk material having uniform dissolution
HU227070B1 (en) * 1999-08-11 2010-06-28 Egis Gyogyszergyar Nyilvanosan Immediate release pharmaceutical composition containing ciprofloxacin and process for its production
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa
FR2816507B1 (fr) * 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
HUP0303178A3 (en) * 2001-02-05 2008-03-28 R P Scherer Technologies Methods and compositions for reducing the taste of pharmaceutically active agents
EP1285649A1 (en) * 2001-08-23 2003-02-26 Cimex AG Bilayered dispersible tablet formulation comprising amoxycillin and clavulanate in separate layers
RU2004123621A (ru) * 2002-02-01 2005-04-10 Пфайзер Продактс Инк. (Us) Лекарственные формы с немедленным высвобождением, содержащие твердые дисперсии лекарств
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
KR20050062514A (ko) * 2002-07-16 2005-06-23 랜박시 래보러터리스 리미티드 경구 투여용 분산성 정제
AU2003247023A1 (en) * 2002-08-02 2004-02-25 Ranbaxy Laboratories Limited A process for the preparation of dispersible tablet of cephalexin
JP4702763B2 (ja) * 2003-07-30 2011-06-15 塩野義製薬株式会社 結晶セルロースを含有する安定な錠剤
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
PL3395338T3 (pl) * 2003-09-12 2019-10-31 Amgen Inc Szybko rozpuszczająca się formulacja zawierająca cynakalcet HCl
US20050089558A1 (en) * 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
EP1681050A1 (en) * 2005-01-13 2006-07-19 Strides Arcolab Limited Dispersible sustained release pharmaceutical compositions
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
WO2008008120A1 (en) * 2006-07-14 2008-01-17 Fmc Corporation Solid form
JP5201819B2 (ja) * 2006-11-22 2013-06-05 エスエス製薬株式会社 固形組成物
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
JP5637624B2 (ja) * 2009-02-12 2014-12-10 富士化学工業株式会社 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物
WO2011152808A1 (en) * 2010-06-03 2011-12-08 Mahmut Bilgic Formulation comprising cefpodoxime proxetil and clavulanic acid
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
WO2013151517A1 (en) * 2012-04-04 2013-10-10 Mahmut Bilgic Tablet formulations comprising cefpodoxime proxetil and clavulanic acid
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN106255512B (zh) 2014-04-21 2021-01-01 株式会社大赛璐 含有微小纤维状纤维素的崩解性颗粒组合物
CN110051639B (zh) * 2019-03-15 2021-08-31 河北嘉迈医药科技有限公司 一种快速崩解型尼麦角林片及其制备方法
CN117683469A (zh) * 2023-10-24 2024-03-12 绍兴拓邦新能源股份有限公司 一种晶硅片背面碱抛光固态添加剂及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1322306A (en) * 1971-04-15 1973-07-04 Meiji Seika Co Stabilized antibiotic preparation and manufacturing process therefor
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
JPS58403B2 (ja) * 1975-07-24 1983-01-06 武田薬品工業株式会社 Ｌ− アスコルビンサンセイザイノ セイゾウホウ
NL184308C (nl) * 1975-07-24 1989-06-16 Takeda Chemical Industries Ltd Werkwijze voor het bereiden van l-ascorbienzuurgranules.
GB1560475A (en) * 1975-10-11 1980-02-06 Lilly Industries Ltd Pharmaceutical formulation
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
EP0200252B1 (en) * 1985-05-02 1999-03-10 Yamanouchi Europe B.V. Tablets comprising trimethoprim and a sulfonamide
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
EP0330284B1 (en) * 1988-02-25 1994-07-27 Yamanouchi Europe B.V. Process for the preparation of a pharmaceutical granulate
US4911921A (en) * 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
IL109097A0 (en) * 1993-04-03 1994-06-24 Knoll Ag Delayed release micro tablet of beta-phenylpropiophenone derivatives and its production

Also Published As

Publication number Publication date
CO4890859A1 (es) 2000-02-28
TR199802762T2 (xx) 1999-03-22
ES2197351T3 (es) 2004-01-01
PL330958A1 (en) 1999-06-21
HUP9903308A2 (hu) 2000-03-28
EA001537B1 (ru) 2001-04-23
DK0910344T3 (da) 2003-07-07
JO1969B1 (en) 1997-12-15
IL127364A (en) 2003-04-10
PL188235B1 (pl) 2004-12-31
CZ699A3 (cs) 1999-04-14
ZA975848B (en) 1999-04-12
MY116124A (en) 2003-11-28
CA2258841C (en) 2006-05-30
BR9710181B1 (pt) 2009-08-11
JP2000513727A (ja) 2000-10-17
JP4159607B2 (ja) 2008-10-01
IL127364A0 (en) 1999-10-28
NO986157L (no) 1999-02-01
WO1998001114A1 (en) 1998-01-15
BG103047A (en) 1999-07-30
EA199900075A1 (ru) 1999-06-24
PT910344E (pt) 2003-09-30
AU731276B2 (en) 2001-03-29
EP0910344A1 (en) 1999-04-28
EG23814A (en) 2007-09-12
BG64114B1 (bg) 2004-01-30
SI0910344T1 (en) 2003-08-31
ATE237314T1 (de) 2003-05-15
CA2258841A1 (en) 1998-01-15
DE69720995T2 (de) 2003-11-13
NO320767B1 (no) 2006-01-23
AU3342197A (en) 1998-02-02
SK284175B6 (sk) 2004-10-05
CN1131025C (zh) 2003-12-17
CN1224348A (zh) 1999-07-28
TNSN97114A1 (fr) 2005-03-15
NO986157D0 (no) 1998-12-28
CZ295893B6 (cs) 2005-11-16
UA61917C2 (uk) 2003-12-15
TW473392B (en) 2002-01-21
NZ333247A (en) 2000-07-28
HU225115B1 (hu) 2006-06-28
DE69720995D1 (de) 2003-05-22
EP0910344B1 (en) 2003-04-16
PE89798A1 (es) 1999-01-12
BR9710181A (pt) 1999-08-10
HK1021511A1 (en) 2000-06-16
HUP9903308A3 (en) 2001-03-28
US5837292A (en) 1998-11-17
SK176798A3 (en) 2000-04-10
ID17128A (id) 1997-12-04

Similar Documents

Publication Publication Date Title
AR008252A1 (es) Granulado para la preparacion de composiciones farmaccuticas de rrpida desintegracinn y rrpida disolucinn y composiciones farmaccuticas que lo contienen
AR008462A1 (es) COMPOSICIoN FARMACÉUTICA QUE COMPRENDE OLANZAPINA Y CLORHIDRATO DE FLUOXETINA Y USO DE DICHA COMPOSICIoN PARA LA FABRICACIoN DE UN MEDICAMENTO.
HUP0003526A2 (en) The use of delayed and/or sustained release vitamin d formulations and pharmaceutical compositions containing d-vitamins
PT998272E (pt) Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
ATE263558T1 (de) Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
PT952829E (pt) Composicao farmaceutica de fenofibrato que apresenta uma biodisponibilidade elevada e seu modo de preparacao
IL123986A0 (en) Antithombotic agents process for their preparation and pharmaceutical compositions comprising them
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
PT96438A (pt) Processo para preparacao de anti-oxidante lipideo-selectivos e de composicoes farmaceuticas que os contem
PT835246E (pt) Compostos aromaticos e composicoes farmaceuticas que os contem
BR9707501A (pt) Composto composição farmacêutica e uso do composto
HUP9902655A3 (en) Pharmaceutical composition of hedgehog proteins and use thereof
BR9612555A (pt) Composições de detergente que contêm precursores de fragância e os precursores de fragância dessas composições
GB2343117B (en) Benzimidazole pharmaceutical composition and process of preparation
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
ATE273697T1 (de) Pharmazeutische levothyroxinzubereitung
PT1014927E (pt) Utilizacao de shogaois e de gingerois para a preparacao de composicoes desodorizantes
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
PT842927E (pt) 3-AMIDO-CROMANILSULFONIL(TIO)-UREIAS PROCESSOS PARA A SUA PREPARACAO SUA UTILIZACAO E COMPOSICOES FARMACêUTICAS QUE AS CONTEM
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
HUP0002012A3 (en) Use of desferriexochelin for the preparation of pharmaceutical compositions treating atherosclerosis and vascular injury
HUP0004223A3 (en) 4-oxo-butynic acids and pharmaceutical composition containing them as active agent
HUP9902119A3 (en) Diphenyl stilbene derivatives as cox-2 inhibitors and pharmaceutical compositions of the same

Legal Events

Date Code Title Description
FG Grant, registration